The report includes national and state level data on lung cancer screening, diagnosis, survival, treatment trends and disparities in care, according to a Nov. 19 news release from the association.

The American Lung Association's new 2024 “State of Lung Cancer” report ranks New York in the top 5 states for early diagnosis ...

CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...

Genprex intellectual property and licensing senior vice-president Thomas Gallagher stated: “We continue to bolster our intellectual property portfolio for REQORSA, understanding ...

Certain chronic conditions that affect the lungs, such as asthma and chronic obstructive pulmonary disease (COPD), can have ...

Alabama ranks near the bottom of the nation for lung cancer survival, with just over one-fifth of diagnosed patients ...

In September, amivantamab (Rybrevant; Johnson & Johnson) received its fourth treatment indication from the FDA to treat ...

The new drug, Jazz Pharmaceuticals’ zanidatamab, has won an FDA accelerated approval for adults with previously treated ...

This year’s “State of Lung Cancer” report reveals mixed news for North Dakota, which ranks 27th nationally for new lung cancer cases, according to the American Lung Association. The report examines ...

A new report from the American Lung Association reveals both progress and persistent challenges in the fight against lung ...

The national survival rate for lung cancer has increased by 26% in the past 5 years, to 28.4% of all cases, according to a ...

These include a drug delivery platform for the treatment of peritoneal cancer, which resulted in the spin-off company NaDeNo. And today, a new cure for lung cancer is on the researchers' agenda.